CERENOME, INC. Net Income (Loss) Available to Common Stockholders, Diluted
CERENOME, INC. (CNSY) reported Net Income (Loss) Available to Common Stockholders, Diluted of -$9.01 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Income Statement › Net Income
us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted · last filed 2026-08-14
- CERENOME, INC. net income (loss) available to common stockholders, diluted for the quarter ending 2026-06-30 was -$9.01M.
- CERENOME, INC. net income (loss) available to common stockholders, diluted for the quarter ending 2025-06-30 was -$1.36M.
- CERENOME, INC. net income (loss) available to common stockholders, diluted for the quarter ending 2024-12-31 was -$3.90M.
- CERENOME, INC. net income (loss) available to common stockholders, diluted for the quarter ending 2024-09-30 was -$2.87M.
- CERENOME, INC. net income (loss) available to common stockholders, diluted for fiscal 2025 was -$22.39M.
- CERENOME, INC. net income (loss) available to common stockholders, diluted for fiscal 2024 was -$18.02M.
- CERENOME, INC. net income (loss) available to common stockholders, diluted for fiscal 2023 was -$13.32M.
| Period end | Net Income (Loss) Available to Common Stockholders, Diluted 3 month | Net Income (Loss) Available to Common Stockholders, Diluted 6 month | Net Income (Loss) Available to Common Stockholders, Diluted 9 month | Net Income (Loss) Available to Common Stockholders, Diluted 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$9.01M 10-Q · filed 2026-08-14 | -$15.95M 10-Q · filed 2026-08-14 | ||
| 2025-12-31 | -$22.39M 10-K · filed 2026-03-12 | |||
| 2025-06-30 | -$1.36M 10-Q · filed 2026-08-14 | -$12.25M 10-Q · filed 2026-08-14 | ||
| 2024-12-31 | -$3.90M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-12 | -$6.78M derived: sum of 2 quarters · filed 2026-03-12 | -$14.41M derived: sum of 3 quarters · filed 2026-03-12 | -$18.02M 10-K · filed 2026-03-12 |
| 2024-09-30 | -$2.87M 10-Q · filed 2024-11-14 | -$10.51M derived: sum of 2 quarters · filed 2025-08-14 | -$14.12M 10-Q · filed 2024-11-14 | |
| 2024-06-30 | -$7.63M 10-Q · filed 2025-08-14 | -$10.89M 10-Q · filed 2025-08-14 | ||
| 2023-12-31 | -$3.81M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31 | -$7.03M derived: sum of 2 quarters · filed 2025-03-31 | -$8.51M derived: sum of 3 quarters · filed 2025-03-31 | -$13.32M 10-K · filed 2025-03-31 |
| 2023-09-30 | -$3.22M 10-Q · filed 2024-11-14 | -$4.70M derived: sum of 2 quarters · filed 2024-11-14 | -$9.51M 10-Q · filed 2024-11-14 | |
| 2023-06-30 | -$1.48M 10-Q · filed 2024-08-14 | -$6.29M 10-Q · filed 2024-08-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| SeaStar Medical Holding Corp (ICU) | United States | $0.015B | -1.14 |
| Sintx Technologies, Inc. (SINT) | United States | $0.012B | -1.10 |
| NEUROONE MEDICAL TECHNOLOGIES Corp (NMTC) | United States | $0.012B | |
| Picard Medical, Inc. (PMI) | United States | $0.011B | -0.01 |
| Modular Medical, Inc. (MODD) | United States | $0.018B | -0.88 |
| ALLURION TECHNOLOGIES, INC. (ALUR) | United States | $0.010B | |
| FEMASYS INC (FEMY) | United States | $0.020B | -1.07 |
| RETRACTABLE TECHNOLOGIES INC (RVP) | United States | $0.021B | -6.44 |
| Co-Diagnostics, Inc. (CODX) | United States | $0.007B | -0.32 |
| HeartBeam, Inc. (BEAT) | United States | $0.022B | -2.08 |